https://www.thebodypro.com/category/pregnancy-childbirth-hiv/tag/women

The Latest

Lynne Mofenson

After Years of Decline, Perinatal HIV Transmission Has Hit a Plateau. Why?

This researcher has some ideas about what we need to do to address the problem.

By Terri Wilder, M.S.W.
vaginal ring

Contraceptives Don’t Increase HIV Risk, but They Do Interact With Some Antiretrovirals

A CROI 2020 roundup of studies on birth control and women living with HIV.

By Barbara Jungwirth
pregnant belly

Tempering Previous Concerns, Study Finds Dolutegravir Safest HIV Treatment During Pregnancy

New data shows the drug is not more likely to cause birth defects.

By Sony Salzman
pregnant woman and partner cuddling on couch

New Study Will Test Safety of PrEP and Dapivirine Ring in Pregnancy

While the vaginal ring is still currently under FDA review, the new study will show whether it is safe and acceptable for people who are pregnant.

By Martha Kempner
close up of cannabis plant

This Week in HIV Research: More Answers—and Questions—on Cannabis Use

Jan. 23, 2020: Neurocognitive benefits of cannabis use; how unquantifiable HIV in CSF correlates to executive function; updated findings on efavirenz and microcephaly; cost-efficacy of a specialized HIV care coordination team.

By Barbara Jungwirth and Myles Helfand
pregnant woman talking to doctor

Raltegravir Not Linked to Birth Defects, Study Shows

Amidst uncertainty regarding the safety of some integrase inhibitors during pregnancy, a study shows that an older integrase inhibitor may be a good option for those with HIV who intend to give birth.

By Kenyon Farrow
Hand holding syringe in backlight

Controversy Erupts Around Study on Contraception and HIV Risk

The ECHO trial faces backlash and criticism.

By Sony Salzman
pregnant stomach

This Week in HIV Research: Pregnancy Findings That Aren't About Dolutegravir

Aug. 1, 2019: Raltegravir OK in pregnancy; HIV disclosure and viral suppression among pregnant women; newborn size following HIV exposure; causes of hearing problems among people with HIV.

By Barbara Jungwirth and Myles Helfand
Fernanda Fernandes Fonseca and Meg Doherty at an IAS 2019 press conference

World Health Organization Updates Guidance on Dolutegravir After Reassuring Data Regarding Safety in Early Pregnancy

New study results leave many experts feeling they went too far in their concerns over birth defect risks associated with the drug.

By Sony Salzman
Mexico City's Downtown At Twilight

IAS 2019: What to Expect in HIV Science

Six thousand HIV researchers and experts are expected to make their way to Mexico City for the 10th International AIDS Society Conference on HIV Science, which will feature more than 1,000 abstracts highlighting the latest findings in HIV treatment, prevention, and public health policy.

By Sony Salzman